phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

PANoptosis emerges as a unified cell-death hub and a promising drug target

PANoptosis is an integrated form of programmed cell death (PCD) that combines features of pyroptosis, apoptosis and necroptosis. This review examines how the PANoptosome--a multiprotein platform built from sensor, adaptor and catalytic components--coordinates these death programs. It surveys five known PANoptosome types, their signaling preferences and the mitochondrial and inflammatory signals that shape their activation. It also assesses PANoptosis in infectious, autoimmune, neurodegenerative, cardiovascular and neoplastic diseases, and evaluates small-molecule inhibitors, nanomedicines and combination therapies designed to suppress or induce the pathway. Overall, PANoptosis is a promising but challenging target for precision medicine.

October 15, 2026


October 23 2026

October 22 2026

October 21 2026

October 20 2026

October 19 2026

October 18 2026

October 17 2026

October 16 2026

October 15 2026

October 14 2026

October 13 2026

October 12 2026

October 11 2026

October 10 2026

October 9 2026

Angell Street Psychiatry
Copyright 2026 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy